neuropathic pain

Vertex Advances VX-548 in Acute and Neuropathic Pain
Yahoo/Businesswire
Fri, 07/22/22 - 10:09 am
Vertex Pharmaceuticals
acute pain
neuropathic pain
FDA
VS-548
clinical trials
VistaGen’s AV-101 Snags Fast Track Designation, Other Drugmakers Move Ahead with Non-Opioid Pain Treatment Programs
BioSpace
Mon, 10/8/18 - 09:53 am
VistaGen
AV-101
FDA
fast track
neuropathic pain
BioWave
Virpax Pharmaceuticals
Pfizer’s Fight Against Off-Patent Uses of Pregabalin Comes to Trial Monday
WSJ Pharmalot
Fri, 06/26/15 - 08:03 pm
Pfizer
pregabalin
off-label
epilepsy
Lyrica
neuropathic pain
Virobay banks $8M to accelerate its treatments for pain, autoimmunity
Fierce Biotech
Thu, 07/17/14 - 10:05 am
Virobay
autoimmune disease
neuropathic pain
VBY-036
VBY-376
Bionomics signs option and license agreement with Merck
Fly On The Wall
Wed, 07/31/13 - 09:02 am
Bionomics
Merck
pain management
neuropathic pain
NeurogesX seeks partners for pain drugs
Reuters
Tue, 04/17/12 - 10:40 am
NeurogesX
Qutenza
neuropathic pain
Bristol-Myers and NeurOp extend deal through 2012
Yahoo/AP
Wed, 12/14/11 - 01:04 pm
Bristol-Myers Squibb
NeurOp
neuropathic pain
Avanir Pharmaceuticals Announces Filing of IND for AVP-923 for the Treatment of Central Neuropathic Pain in Patients with Multiple Sclerosis
Yahoo
Mon, 04/4/11 - 11:37 am
neuropathic pain
MS
multiple sclerosis
AVP-923
Avanir
Cannasat Therapeutics Announces Private Placement
PR-USA
Sat, 04/10/10 - 01:14 pm
Cannasat Therapeutics
Parkinson's Disease
neuropathic pain
Depomed files marketing application for pain drug
Reuters
Wed, 03/31/10 - 11:18 am
Depomed
neuropathic pain
Raptor Pharma's NGX426 For Pain Relief Proves Effective In Test
RTT News
Mon, 11/23/09 - 10:20 am
Raptor Pharmaceuticals
neuropathic pain
drug trials
XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
Yahoo/AP
Mon, 11/9/09 - 10:10 am
XenoPort
FDA
GSK
neuropathic pain
Glaxo reports positive Phase 2 PHN drug study
Marketwatch
Mon, 10/5/09 - 10:25 am
GSK
neuropathic pain
drug studies
GlaxoSmithKline, Xenoport report positive midstage study results from potential pain drug
Yahoo/AP
Thu, 09/17/09 - 11:16 am
GSK
XenoPort
neuropathic pain
NeurogesX Fundamentals Improve
Seeking Alpha
Tue, 03/24/09 - 09:27 am
NeurogesX
Qutenza
neuropathic pain
King Pharmaceuticals Initiates Phase II Clinical Trial Evaluating T-62 as a Treatment for Neuropathic Pain
Business Wire
Sat, 12/27/08 - 11:23 am
King
T-62
neuropathic pain